Gut Microbiota Dysbiosis Mediates 125 I‐Induced Radiation Colitis via Host Transcriptional Regulation
Immunity, Inflammation and Disease · 2026
DOI: 10.1002/iid3.70523 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2026. Verfasst von Pingping Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging, Sichuan Corps Hospital of PAP, Leshan, China. Hauptthemen laut MEDLINE: Colitis, Gastrointestinal Microbiome, Dysbiosis, Iodine Radioisotopes. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China., National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Iodine‐125 ( 125 I) seed therapy is recognized for treating abdominal solid tumors with minimal adjacent tissue damage but may induce radiation colitis when its implantation near colonic tissues, leading to a poor prognosis. Nevertheless, the underlying pathogenesis is not well understood.
Objective
This research aims to investigate the role of gut microbiota and host immune‐transcriptional responses in the pathogenesis of 125 I‐induced radiation colitis.
Methods
We implanted 125 I seeds intraperitoneally in mice and assessed colonic damage via histology, TUNEL staining, cytokine assays, and tight‑junction protein measurements. Fecal microbiota were profiled by 16S rRNA sequencing, and colonic transcriptomes by RNA‑seq. Multi‑omics integration (Spearman correlation, KEGG, RDA, Procrustes) was used to link microbial taxa, differentially expressed genes, and pathological features.
Results
125 I exposure caused mucosal necrosis, lowered ZO‐1 and occludin levels, and raised IL‐1α, IL‐1β, IL‐6, and TNF‐α. 16S rRNA sequencing revealed altered microbial β‐diversity and dysbiosis, characterized by reduced Lachnospiraceae , Mucispirillum , and Desulfovibrio , and increased Clostridium methylpentosum and Bifidobacterium . RNA‐seq analysis revealed differentially expressed genes such as Angptl7, Apoh, C7, and Ccl7. Integrated analyses, including Spearman correlation, KEGG enrichment, redundancy analysis, and Procrustes analysis, confirmed strong associations between certain microbes, host gene expression, and pathological phenotypes.
Conclusion
Our findings indicate that 125 I irradiation is associated with gut dysbiosis and concurrent host immune‑transcriptional reprogramming, which may jointly contribute to radiation colitis. Although these results lay a foundation for microbiota‑targeted interventions, the causative role of microbial changes remains to be confirmed by functional experiments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Imaging, Sichuan Corps Hospital of PAP, Leshan, China.
- Department of General Surgery, Xinqiao Hospital, Army Medical University, Chongqing, China.
- Department of General Surgery, The First Mobile Corps Hospital of PAP, Dingzhou, China.
- Department of Laboratory Medicine, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
ORCID-Profile: Xiong Zeng, Yihui Chen
Förderung
- National Natural Science Foundation of China.
- National Natural Science Foundation of China
Zitieren
APA
Liu, P., Zeng, X., Liu, W., Xie, H., Fang, Y., Yang, E., Tang, X., Fan, C., & Chen, Y. (2026). Gut Microbiota Dysbiosis Mediates 125 I‐Induced Radiation Colitis via Host Transcriptional Regulation. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.70523
Vancouver
Liu P, Zeng X, Liu W, Xie H, Fang Y, Yang E, et al. Gut Microbiota Dysbiosis Mediates 125 I‐Induced Radiation Colitis via Host Transcriptional Regulation. Immunity, Inflammation and Disease. 2026. doi:10.1002/iid3.70523
BibTeX
@article{Liu2026,
author = {Liu, Pingping and Zeng, Xiong and Liu, Wenjing and Xie, Huichao and Fang, Yongkun and Yang, Erwan and Tang, Xiaoqi and Fan, Chenglin and Chen, Yihui},
title = {Gut Microbiota Dysbiosis Mediates 125 I‐Induced Radiation Colitis via Host Transcriptional Regulation},
journal = {Immunity, Inflammation and Disease},
year = {2026},
doi = {10.1002/iid3.70523}
}
EUVIMED